Sleep Disturbance in Dementia — MRCPsych Paper B MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Trazodone 50 mg at night
Explanation lettering: D = shown as A · A = shown as B · B = shown as C · C = shown as D
D is correct. A small placebo-controlled trial, summarised in a Cochrane review, found that trazodone 50 mg nightly increased total nocturnal sleep time by about 42 minutes and improved sleep efficiency in moderate-to-severe Alzheimer's disease. The evidence is low-certainty, and prescribing trazodone for insomnia is off-label; this is not a routine NICE recommendation. NICE prioritises personalised multicomponent sleep management and specifically advises not offering melatonin for insomnia in Alzheimer's disease. Melatonin showed little or no benefit in pooled trials. Zopiclone and diazepam lack direct trial evidence in dementia and may worsen sedation, confusion and falls. Amitriptyline has substantial anticholinergic and postural adverse effects and may exacerbate cognitive impairment.
Reference: McCleery J, Sharpley AL. Pharmacotherapies for sleep disturbances in dementia. Cochrane Database of Systematic Reviews. 2020;11:CD009178. https://www.nice.org.uk/guidance/ng97/chapter/Recommendations